CDKN1A and malignant colon neoplasm: To elucidate the potential of M1 virus personalized therapy by detecting CDKN1A deficiency, we compared the expression of CDKN1A in both tumor and adjacent non‐neoplastic tissue specimens from 38 colon cancer patients in the TCGA database [36].